Publications


Polygenic risk impacts PDGFRA mutation penetrance in non-syndromic cleft lip and palate;
Yu, Y, Alvarado, R, Petty, LE, Bohlender, RJ, Shaw, DM, Below, JE, Bejar, N, Ruiz, OE, Tandon, B, Eisenhoffer, GT, Kiss, DL, Huff, CD, Letra, A & Hecht, JT 2022, , Human Molecular Genetics, vol. 31, no. 14, pp. 2348-2357. https://doi.org/10.1093/hmg/ddac037

Editorial: mRNA Translational Control as a Mechanism of Post-transcriptional Gene Regulation;
Kiss, DL, Vasudevan, D, Ho, CK & Caliskan, N 2022, , Frontiers in Molecular Biosciences, vol. 9, 947516. https://doi.org/10.3389/fmolb.2022.947516

Biomimetic Collagen Membranes Functionalized with mRNA-loaded Lipid Nanoparticles for Fibroblast Transdifferentiation to Endothelial Cells;
Villarreal-Leal, RA, Williams, ME, Taraballi, F, Cooke, JP & Corradetti, B 2022, , FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol. 36. https://doi.org/10.1096/fasebj.2022.36.S1.L7813

Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications;
Banerjee, P, Olmsted-Davis, EA, Deswal, A, Nguyen, MT, Koutroumpakis, E, Palaskas, NL, Lin, SH, Kotla, S, Reyes-Gibby, C, Yeung, S-CJ, Yusuf, SW, Yoshimoto, M, Kobayashi, M, Yu, B, Schadler, K, Herrmann, J, Cooke, JP, Jain, A, Chini, E, Le, N-T & Abe, J-I 2022, , The journal of cardiovascular aging, vol. 2. https://doi.org/10.20517/jca.2022.13

Loop Between NLRP3 Inflammasome and Reactive Oxygen Species;
Dominic, A, Le, N-T & Takahashi, M 2022, , Antioxidants and Redox Signaling, vol. 36, no. 10-12, pp. 784-796. https://doi.org/10.1089/ars.2020.8257

RBFOX2 is required for establishing RNA regulatory networks essential for heart development;
Verma, SK, Deshmukh, V, Thatcher, K, Belanger, KAK, Rhyner, AM, Meng, S, Holcomb, RJ, Bressan, M, Martin, JF, Cooke, JP, Wythe, JD, Widen, SG, Lincoln, J & Kuyumcu-Martinez, MN 2022, , Nucleic Acids Research, vol. 50, no. 4, pp. 2270-2286. https://doi.org/10.1093/nar/gkac055

RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases;
Bejar, N, Tat, TT & Kiss, DL 2022, , Current Atherosclerosis Reports, vol. 24, no. 5, pp. 307-321. https://doi.org/10.1007/s11883-022-01007-9

Free Cholesterol Bioavailability and Atherosclerosis;
Abe, RJ, Abe, JI, Nguyen, MTH, Olmsted-Davis, EA, Mamun, A, Banerjee, P, Cooke, JP, Fang, L, Pownall, H & Le, NT 2022, , Current Atherosclerosis Reports, vol. 24, no. 5, pp. 323-336. https://doi.org/10.1007/s11883-022-01011-z